ERIC ENGLUND: Open Payments
NPI 1518999382 · PLYMOUTH, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 11 payments from 9 companies in 2025. Trend: 2023 $265 · 2024 $188 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| Surgenex LLC | 1 | $39 |
| Organon LLC | 3 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Incyte Corporation | 1 | $26 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Galderma Laboratories, L.P. | 1 | $14 |
| Novartis Pharmaceuticals Corporation | 1 | $13 |
Products named: SurGraft, DUPIXENT, OPZELURA, Zoryve, Otezla, Sotyktu, NEMLUVIO, Rhapsido.
Industry payments across MN — which companies pay providers there.
